Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 60.47B INR in the quarter ending September 30, 2025, with 76.10% growth. This brings the company's revenue in the last twelve months to 159.97B, up 22.30% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.

• Revenue (ttm): 159.97B
• Revenue Growth: +22.30%
• P/S Ratio: 3.45
• Revenue / Employee: 10.12M
• Employees: 15,800
• Market Cap: 552.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	133.63B	7.18B	5.68%
Mar 31, 2024	126.45B	9.90B	8.49%
Mar 31, 2023	116.56B	-6.49B	-5.28%
Mar 31, 2022	123.05B	13.61B	12.44%
Mar 31, 2021	109.44B	2.87B	2.69%